Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium - Wikidata - wikimedia - TriplyDB

Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium

Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium

http://www.wikidata.org/entity/Q35915270

about

A review of the LARIAT device: insights from the cumulative clinical experience Percutaneous Left Atrial Appendage Ligation for Stroke Prevention in Atrial Fibrillation Left Atrial Appendage: Physiology, Pathology, and Role as a Therapeutic Target Intentional Right Atrial Exit and Carbon Dioxide Insufflation to Facilitate Subxiphoid Needle Entry Into the Empty Pericardial Space: First Human Experience.The Cost Effectiveness of LAA Exclusion Anticoagulation in Heart Failure: a Review Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies.Left atrial appendage closure to prevent stroke in patients with atrial fibrillation Atrial fibrillation ablation and left appendage closure in heart failure patients A Review of the LARIAT Suture Delivery Device for Left Atrial Appendage Closure.Intentional right atrial exit for microcatheter infusion of pericardial carbon dioxide or iodinated contrast to facilitate sub-xiphoid access.Anticoagulation in Heart Failure: a Review.Regional function analysis of left atrial appendage using motion estimation CT and risk of stroke in patients with atrial fibrillation Non-Pharmacologic Approach to Prevent Embolization in Patients with Atrial Fibrillation in Whom Anticoagulation is Contraindicated.Antithrombotic therapy after left atrial appendage closure.Left atrial appendage occlusion.An overview of left atrial appendage occlusion devices.Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview: A professional societal overview from the American College of Cardiology, Heart Rhythm Society, and Society for Cardiovascular Angiography and Interventions.Republished: Left atrial appendage occlusion.Role of Endovascular Closure of the Left Atrial Appendage in Stroke Prevention for Atrial Fibrillation.Interventional and surgical occlusion of the left atrial appendage.ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: indications, patient selection, staff skills, organisation, and training.Left atrial appendage occlusion: rationale, evidence, devices, and patient selection.Incomplete Closure of the Left Atrial Appendage: Implication and Management.Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation.Left atrial appendage closure: outcomes and challenges Left Atrial Appendage Ligation And Exclusion Technology In The Incubator.Left Atrial Appendage Ligation and Exclusion Technology in the Incubator.Incomplete surgical ligation of the left atrial appendage-time for a new look at an old problem.Reply: Differences in experience with a new delivery device for LAA ligation among various U.S. centers A meta-analysis of left atrial appendage closure for stroke prevention in atrial fibrillation-adding to the debate but elements remain unresolved.Left atrial appendage closure: killing 2 birds with 1 stone?2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.Impact of Periprocedural Colchicine on Postprocedural Management in Patients Undergoing a Left Atrial Appendage Ligation Using LARIAT.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.Sequential Percutaneous LAA Ligation and Pulmonary Vein Isolation in Patients with Persistent AF: Initial Results of a Feasibility Study.Percutaneous Left Atrial Appendage Closure: is there a Role in Valvular Atrial Fibrillation.Leaks after left atrial appendage ligation with Lariat device: Incidence, pathophysiology, clinical implications and methods of closure- A case based discussion.

P2860

Q26781162-EEFBC49D-F237-4146-A041-E4A758A00476 Q26797439-F41C1AAC-5BEE-4CB6-9F1B-7AAB3478D120 Q26799847-B088D5D8-9406-4A78-B236-F765664EC3BB Q27310489-CBE0476A-E610-4161-8FCD-640347E5A26C Q28072579-7028156A-FBD7-4B55-BFBB-9920043E7613 Q28087068-C08D8CA8-E754-4F53-8080-3254A12630E2 Q31122441-A8DBF451-2606-40BE-992C-E50B0DDC3603 Q34080391-7DE16946-507F-4137-B8EB-452E4D269D41 Q35755766-76CB2A84-3C2E-44E5-AC4F-0DFF7B69B291 Q35768715-058A3886-F127-46DE-B8C5-9B4D3CD0D1AB Q35956975-569A2F28-7736-439A-9651-E5F62639AA82 Q36381170-41F98DE4-3CAD-4D5B-8E90-823BE0726179 Q37002984-61A492CA-9256-446B-AFD9-58A2BC56EE9B Q37605085-E4A425AB-536C-4BBE-87D4-B13D04B90FBD Q38272769-CC58ED22-D7B7-4533-8C74-8C19BC227657 Q38292081-CB5C2976-CE8D-4DCC-8C72-DAE6A26BEB52 Q38366102-74EC0C90-C5B0-49FF-9B1E-0D9D55F71BE9 Q38526411-21AFFADB-BB25-4912-9844-1ABD8341AF7B Q38563391-42DD31FF-2FFD-48DF-8D1A-9AB22BB67A0D Q38580613-A5D65346-822F-49C9-AB26-61B0CF7CEEDE Q38593072-58E6ED30-E68E-4F99-A879-328798BF73A0 Q38630969-C5C32BC8-0180-40C4-BB82-152179E5F559 Q38656357-ED5A7D5F-03B5-4B2E-9B5D-B05900B37D2C Q38821262-75984C13-0CE7-456B-A8C3-D853E7574022 Q38904529-16300178-EB52-4335-8F96-7353EB637E37 Q38970641-DCF962F0-76BA-40A4-B04D-36C4124B87D0 Q39036222-3F58A3C1-D935-4A15-B956-A1F4B298E459 Q39037108-1B4ACF1A-7A9D-4852-B748-921F89BEFF6A Q40114531-53D6CED3-E676-4412-B098-597F19CCC35E Q42361709-7EB856AF-FF2A-4F0F-83DF-51C003184DC8 Q42414804-A5EF9247-A6B9-4803-83D6-AEEABABB4847 Q43114807-1FE508F3-6F7F-41B3-9797-EDAAE8D83EF7 Q43228084-25095698-E38E-4A02-8A25-F3FFDB55650F Q45059153-0A8A7771-ECA8-45AB-9187-78FE79BD7783 Q45974877-DE39DA92-7CD5-43D9-A4DC-2998383F6014 Q46007774-CDDC6FA9-58F0-41AA-8B03-02609CCF5D94 Q46658026-24B9B217-197F-4CF8-923D-E9AFD6E2D44F Q46691597-89639126-E372-4F6A-9204-CE2A7534E149 Q47149613-27AF1061-3A48-4065-A90E-2C5CD96E294E Q47159202-1F254D86-F952-4F7A-941E-D589FF353A26

P2860

Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium

http://www.wikidata.org/entity/Q35915270

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Early safety and efficacy of p ...... theter LAA ligation consortium

@ast

Early safety and efficacy of p ...... theter LAA ligation consortium

@en

type

label

Early safety and efficacy of p ...... theter LAA ligation consortium

@ast

Early safety and efficacy of p ...... theter LAA ligation consortium

@en

prefLabel

Early safety and efficacy of p ...... theter LAA ligation consortium

@ast

Early safety and efficacy of p ...... theter LAA ligation consortium

@en

P1433

Q35915270-E25BDD6F-2AE4-4A79-988F-3E3AB748F9E8

P1476

Q35915270-C3A90158-7FC6-465A-802F-C4C9B8C75925

P2093

Q35915270-0F416C8D-ECE9-4399-A852-F4053DCA7379

Q35915270-14EB0D99-26B7-4B70-B0AA-0A8A9DF129D4

Q35915270-2EAA7974-BDB4-475E-A6D7-9D8687C30C00

Q35915270-4784880A-3D5D-417D-806E-CC63991F1CB1

Q35915270-7A91ECE5-FEAC-4EB9-A126-A4DAA364FE38

Q35915270-8A1820B8-AE9E-46B7-9553-0BBAE1329315

Q35915270-91D771C5-CE7B-4B81-B705-A63073DCFE6E

Q35915270-98495391-C123-4F5F-80DD-580FD8577120

Q35915270-C622EDB1-2073-464B-AF8E-A4E025F57854

Q35915270-C6C8AE1C-D6A8-43BC-B3ED-5AC976C24A8A

P2860

Q35915270-035B3A1E-1AD8-4CB4-901C-EE12BA4FA2DE

Q35915270-0ABA313F-5342-473C-A80A-788432501C94

Q35915270-11265ABA-8C73-4A8A-82B1-691990F7665F

Q35915270-1EAE07B4-A354-489A-A39F-A2780BC3CDE4

Q35915270-377E0932-5ABF-4905-B1C3-5750E969753C

Q35915270-4D9D1733-D6B3-42D7-BB53-8C2D490E5EB2

Q35915270-649DE2E8-ADE6-482A-9967-A32EB5B5BD40

Q35915270-64B608EE-D212-433A-9D17-273480F4B550

Q35915270-72A2D21B-6489-4493-A105-C6640C030B5A

Q35915270-746DACA4-5E34-446E-8038-AA17393B20AE

P304

Q35915270-BD78FECE-868B-4684-B846-94D49D6ED75E

P31

Q35915270-4FB95A19-AAC3-4C8F-B04E-6CF0F8B7436B

P356

Q35915270-9AA12C34-A49C-4065-8A69-E64E9F279D6F

P407

Q35915270-DC285574-1526-4CAD-911B-6AA5BFA9068A

P433

Q35915270-7960662C-9821-4F63-B2CA-703C58AC2758

P478

Q35915270-465A219C-B8D6-4BAE-9548-DA3F2FAD7FBB

P50

Q35915270-ED2E17C6-9724-450B-AD0F-C0547D4B5626

P577

Q35915270-99971156-E282-44F7-AB5D-94AF7CD726BE

P698

Q35915270-076C5741-605B-4227-BE06-CB3D369C4B1D

P932

Q35915270-500A749C-59F5-477C-B68D-C00EB546A5A0

P356

J.JACC.2014.03.057

P1433

Journal of the American College of Cardiology

P1476

Early safety and efficacy of p ...... theter LAA ligation consortium

@en

P2093

Albert C Lin

http://www.w3.org/2001/XMLSchema#string

Andrea Natale

http://www.w3.org/2001/XMLSchema#string

Ashish Pershad

http://www.w3.org/2001/XMLSchema#string

Bradley Knight

http://www.w3.org/2001/XMLSchema#string

Brett Gidney

http://www.w3.org/2001/XMLSchema#string

Douglas N Gibson

http://www.w3.org/2001/XMLSchema#string

J David Burkhardt

http://www.w3.org/2001/XMLSchema#string

Jason C Schultz

http://www.w3.org/2001/XMLSchema#string

Jeffrey Goldstein

http://www.w3.org/2001/XMLSchema#string

Joseph R Aragon

http://www.w3.org/2001/XMLSchema#string

P2860

Dabigatran versus warfarin in patients with atrial fibrillation

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Edoxaban versus warfarin in patients with atrial fibrillation

Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial.

Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly

Apixaban in patients with atrial fibrillation.

Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

P304

565-572

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2014.03.057

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25104525

http://www.w3.org/2001/XMLSchema#string

P932

4524558

http://www.w3.org/2001/XMLSchema#string